GSK plc (GSK) ORD GBP0.3125

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
GSK buys Boston's developmental liver disease drug for up to $2bn
14 May 2025 07:18
(Sharecast News) - GSK announced on Wednesday that it has entered into an agreement with Boston Pharmaceuticals to acquire its lead asset Efimosfermin for up to $2bn, buying a specialty medicine to treat and...
-
Pharma stocks slide as Trump threatens price cuts in US
12 May 2025 10:13
(Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash the price of prescription drugs for Americans.
-
Sunday newspaper round-up: US-China, Aerospace, Pharma
11 May 2025 14:38
(Sharecast News) - The US president said talks with China that were taking place in Geneva had achieved a "total reset" in the two countries' trade relations. Without elaborating, Donald Trump...
-
London close: FTSE snaps 16-day win streak ahead of Fed
7 May 2025 15:05
(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the US Federal Reserve's policy decision weighed on...
-
GSK, AstraZeneca slide after FDA unveils new vaccine lead
7 May 2025 11:32
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
-
GSK's Nucala delivers positive outcomes in published trial results
1 May 2025 09:54
(Sharecast News) - GSK announced on Thursday that its monoclonal antibody 'Nucala', or mepolizumab, delivered a statistically significant and clinically meaningful reduction in exacerbations for...
-
London close: Stocks finish higher as US economy contracts
30 April 2025 14:52
(Sharecast News) - London stocks extended their gains on Wednesday, after fresh data from the US showed a slowing in consumer price growth, alongside the country's first economic contraction since 2022.
-
GSK confirms guidance after strong first quarter
30 April 2025 07:02
(Sharecast News) - GSK reiterated shrugged off the potential impact of tariffs on Wednesday and reiterated its full-year outlook, following a strong start to the year.
-
Two GSK vaccines get US CDC recommendations
17 April 2025 07:27
(Sharecast News) - GSK announced two important endorsements from the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) on Thursday, for its...
-
London close: Stocks fall as China retaliates to latest US tariffs
9 April 2025 15:07
(Sharecast News) - London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled retaliatory tariffs in response to a sweeping 104% import charge...
-
London close: Stocks slide in global reaction to Trump tariffs
3 April 2025 15:29
(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight.
-
UK pharma stocks avoid selloff
3 April 2025 10:18
(Sharecast News) - GSK and AstraZeneca avoided the selloff on Thursday as pharmaceutical products were exempt from Donald's Trump's tariffs.
Company announcements Announcements
-
Transaction in Own Shares
15 May 2025 07:00
GSK
-
GSK to acquire efimosfermin
14 May 2025 07:00
GSK
-
Transaction in Own Shares
14 May 2025 07:00
GSK
-
Director/PDMR Shareholding
13 May 2025 15:30
GSK
-
Update on belrestotug development programme
13 May 2025 12:56
GSK
-
Transaction in Own Shares
13 May 2025 07:00
GSK
-
Block listing Interim Review
12 May 2025 15:31
GSK
-
Transaction in Own Shares
12 May 2025 07:00
GSK
-
Transaction in Own Shares
9 May 2025 07:00
GSK
-
Director/PDMR Shareholding
8 May 2025 17:15
GSK
-
Director/PDMR Shareholding
8 May 2025 15:30
GSK
-
Linerixibat GLISTEN pIII trial data at EASL
8 May 2025 11:15
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.